BISMUTH SUBSALICYLATE TABLETS

Bismuth subsalicylate tablets are procured under a U.S. Defense Logistics Agency contract with strict technical and packaging requirements. Each tablet contains 262 mg of bismuth subsalicylate and 140 mg of calcium, is sugar-free, and is packaged in units of 48 individually sealed tablets, defined as one package (PG). The product must have a total shelf life of 36 months with at least 31 months remaining upon receipt by the first government activity. Storage must avoid excessive heat above 104°F or 40°C. All labeling and marking must comply with Medical Marking Standard No. 1A dated February 4, 2013, and packaging must adhere to MIL-STD-129 and DLA’s packaging requirements, superseding ASTM D3951 where applicable. The material is not hazardous under FED-STD-313 and must be commercially packaged accordingly, with palletization following RP001 standards. The contract specifies two delivery lines for a total of 77 packages, with delivery required within five days to the USS Theodore Roosevelt CVN 71 at FPO AP 96632. Shipments must use traceable transportation methods and cannot be sent via parcel post. The NSN 6505012448010 applies to both lines, and the units of issue are defined per the DoD authorized system. The procurement is governed by the DLA Master List of Technical and Quality Requirements, and all documentation must reference correct NDC codes, contract line item numbers, and procurement identifiers. The solicitation number is SPE2DP-26-T-4445, issued by the Department of Defense Medical Supply Chain, with a response deadline of August 10, 2026, and a required delivery date of August 5, 2026. No quantity variance is permitted, and acceptance occurs at the destination point upon inspection.